Clinical Trial: ALLIANCE A012301

ALLIANCE A012301

Status: New, Open

LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-Risk Early-Stage Breast Cancer

Eligible for screening study DCP 001

Montana Cancer Consortium will not be participating in the ICAREdata® project in this protocol.